相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Activation of tumor suppressor protein PP2A inhibits KRAS-driven tumor growth
Jaya Sangodkar et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
N-Myc Induces an EZH2-Mediated Transcriptional Program Driving Neuroendocrine Prostate Cancer
Etienne Dardenne et al.
CANCER CELL (2016)
N-Myc Drives Neuroendocrine Prostate Cancer Initiated from Human Prostate Epithelial Cells
John K. Lee et al.
CANCER CELL (2016)
Genomic analyses identify molecular subtypes of pancreatic cancer
Peter Bailey et al.
NATURE (2016)
Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer
Himisha Beltran et al.
NATURE MEDICINE (2016)
Cancer Statistics, 2015
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarcinoma
Pawel K. Mazur et al.
NATURE MEDICINE (2015)
Detection of Circulating Pancreas Epithelial Cells in Patients With Pancreatic Cystic Lesions
Andrew D. Rhim et al.
GASTROENTEROLOGY (2014)
Targeting Inhibitors of the Tumor Suppressor PP2A for the Treatment of Pancreatic Cancer
Amy S. Farrell et al.
MOLECULAR CANCER RESEARCH (2014)
Activation and repression by oncogenic MYC shape tumour-specific gene expression profiles
Susanne Walz et al.
NATURE (2014)
Targeting c-MYC by antagonizing PP2A inhibitors in breast cancer
Mahnaz Janghorban et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Intratumoral functional heterogeneity and chemotherapy
Ferenc Sipos et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Evolving concepts of tumor heterogeneity
Victoria R. Zellmer et al.
CELL AND BIOSCIENCE (2014)
Single-Cell RNA Sequencing Identifies Extracellular Matrix Gene Expression by Pancreatic Circulating Tumor Cells
David T. Ting et al.
CELL REPORTS (2014)
Transformation into large-cell neuroendocrine carcinoma associated with acquired resistance to erlotinib in nonsmall cell lung cancer
Jeong Uk Lim et al.
KOREAN JOURNAL OF INTERNAL MEDICINE (2014)
Breast cancer intra-tumor heterogeneity
Luciano G. Martelotto et al.
BREAST CANCER RESEARCH (2014)
Pancreas Organogenesis: From Lineage Determination to Morphogenesis
Hung Ping Shih et al.
ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, VOL 29 (2013)
Dormant Cancer Cells Contribute to Residual Disease in a Model of Reversible Pancreatic Cancer
Wan-chi Lin et al.
CANCER RESEARCH (2013)
Pin1 Regulates the Dynamics of c-Myc DNA Binding To Facilitate Target Gene Regulation and Oncogenesis
Amy S. Farrell et al.
MOLECULAR AND CELLULAR BIOLOGY (2013)
Transformation to high grade neuroendocrine carcinoma as an acquired drug resistance mechanism in EGFR-mutant lung adenocarcinoma
S. Popat et al.
LUNG CANCER (2013)
Cross Modulation between the Androgen Receptor Axis and Protocadherin-PC in Mediating Neuroendocrine Transdifferentiation and Therapeutic Resistance of Prostate Cancer
Stephane Terry et al.
NEOPLASIA (2013)
EMT and Dissemination Precede Pancreatic Tumor Formation
Andrew D. Rhim et al.
CELL (2012)
Phosphorylation Regulates c-Myc's Oncogenic Activity in the Mammary Gland
Xiaoyan Wang et al.
CANCER RESEARCH (2011)
BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc
Jake E. Delmore et al.
CELL (2011)
Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy
Eric A. Collisson et al.
NATURE MEDICINE (2011)
Molecular Characterization of Neuroendocrine Prostate Cancer and Identification of New Drug Targets
Himisha Beltran et al.
CANCER DISCOVERY (2011)
Pim1 kinase synergizes with c-MYC to induce advanced prostate carcinoma
J. Wang et al.
ONCOGENE (2010)
Notch2 is required for progression of pancreatic intraepithelial neoplasia and development of pancreatic ductal adenocarcinoma
Pawel K. Mazur et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
The Axin1 scaffold protein promotes formation of a degradation complex for c-Myc
Hugh K. Arnold et al.
EMBO JOURNAL (2009)
Reprogramming pancreatic exocrine cells to β-cells
[Anonymous]
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
In vivo reprogramming of adult pancreatic exocrine cells to β-cells
Qiao Zhou et al.
NATURE (2008)
Gemcitabine chemoresistance and molecular markers associated with gemcitabine transport and metabolism in human pancreatic cancer cells
Y. Nakano et al.
BRITISH JOURNAL OF CANCER (2007)
Neuroendocrine-like prostate cancer cells: Neuroendocrine transdifferentiation of prostate adenocarcinoma cells
Ta-Chun Yuan et al.
ENDOCRINE-RELATED CANCER (2007)
Immunohistochemical and genetic evaluation of deoxycytidine kinase in pancreatic cancer: Relationship to molecular mechanisms of gemcitabine resistance and survival
V Sebastiani et al.
CLINICAL CANCER RESEARCH (2006)
c-Myc phosphorylation is required for cellular response to oxidative stress
B Benassi et al.
MOLECULAR CELL (2006)
Lineage tracing and characterization of insulin-secreting cells generated from adult pancreatic acinar cells
K Minami et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Trp53R172H and KraSG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice
SR Hingorani et al.
CANCER CELL (2005)
A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells
E Yeh et al.
NATURE CELL BIOLOGY (2004)
Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse
SR Hingorani et al.
CANCER CELL (2003)
Androgen receptor represses the neuroendocrine transdifferentiation process in prostate cancer cells
ME Wright et al.
MOLECULAR ENDOCRINOLOGY (2003)
Immortalization with telomerase of the Nestin-positive cells of the human pancreas
KM Lee et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability
R Sears et al.
GENES & DEVELOPMENT (2000)
分享论文
